MORRISVILLE – Tenax Therapeutics, formerly known as Oxygen Biotherapeutics, has raised $5 million from an investor, according to an SEC filing.
The news comes after Tenax recently regained compliance with the Nasdaq for its stock (TENX), receiving positive news about a treatment under clinical development and adding two new board members.
